Heme Malignancy

Seraseq Myeloid ctDNA Mix WT

Material Number 0710-2646
Size 1 x 25 µL
Inventory Status In Stock
Unit EA

To help clinical labs performing NGS-based myeloid testing characterize the limit of detection (LOD) of their liquid biopsy assays and validate robust sensitivity, SeraCare has developed myeloid cancer NGS reference material in ctDNA format to ensure compatibility with existing and emerging myeloid assays.

  • Single sample with 25 clinically relevant DNA variants across 17 genes
  • Expert-designed to ensure coverage across important variants (mix of SNVs, INDELs, and ITD) at relevant allele frequencies (1%, 0.5%, 0.1%, WT)
  • Built with innovative technology to produce patient-like sample performance in NGS assays
  • Variants precisely quantified using highly sensitive digital PCR assays, and blended with a single well-characterized genomic background (GM24385)
  • Validated by targeted NGS panels
  • Manufactured in GMP-compliant, ISO 13485-certified facilities

Seraseq ctDNA Myeloid Mix Non-Requirement Letter

Doc type
Safety Data Sheet (Non-Requirement Letter)

Seraseq ctDNA Myeloid Mix AF1%, AF0.5%, AF0.1%, WT Package Insert

Doc type
Package Insert

Seraseq Myeloid Reference Materials: DNA, RNA Fusion, ctDNA Product Sheet

Doc type
Product Sheet

Seraseq Myeloid ctDNA Mix Technical Spreadsheet

Doc type
Technical Spreadsheet

Seraseq ctDNA Myeloid Mix AF1%, AF0.5%, AF0.1%, WT

Doc type
Safety Data Sheet (Non-Requirement Letter)

Seraseq ctDNA Myeloid Mix WT

Doc type
Technical Product Report
Lot #
Product Specifications
# of Variants 25
Allele Frequency 0% (WT)
Concentrations 15 ng/µL 
Amount 375 ng (single vial)
Buffer 1 mM Tris, 0.1 mM EDTA, 10 mM KCl, pH 8.0

Somatic Cancer FAQs

Review the common questions we receive from our customers and the responses we provide.